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The productivity of bioengineered cell factories is limited by inefficiencies in nutrient
delivery and waste and product removal. Current solution approaches explore changes in the
physical configurations of the bioreactors. This work studies the possibilities of exploiting
self-organizing vascular networks to support producer cells within the factory. A compu-
tational model simulates de novo vascular development of endothelial-like cells and the
resultant network functioning to deliver nutrients and extract product from the cell culture.
Microbial factories with vascular networks are evaluated for their scalability, robustness,
and productivity compared to the cell factories without a vascular network. Initial studies
demonstrate at least an order of magnitude increase in production is possible; the system
can be scaled up, and that the self-organization of the efficient vascular network is robust.
The work suggests that bioengineered multicellularity may offer efficiency improvements




Exploiting Self-Organization in Bioengineered Systems:
A Computational Approach
Delin Davis
Bio-reactors, also known as microbial factories are used extensively to produce various
industrially valuable products. However, scalability and stability of these factories are
limited as it is difficult to deliver nutrients and extract product and waste from a large
system. Current solution approaches explore changes in the physical configuration of the
bio-reactors. Inspired from the nutrient delivery mechanisms of large organisms in nature,
this work studies the possibilities of exploiting self-organizing bio-engineered cells which are
capable of organizing into a vessel network to support the producer cells in the factory.
Primary goal of this dissertation is to design a proof-of-concept bio-reactor simula-
tion in which self-organized vessel network function as the nutrient delivery and waste
removal mechanism, which can be formed from a random distribution of bio-engineered
vessel cells. A computational model simulates development of vessels from randomly dis-
tributed endothelial-like cells and the resultant network functioning to deliver nutrients and
extract product from the cell culture.
Microbial factories with vascular networks are evaluated for their scalability, robustness,
and productivity compared to the cell factories without a vascular network. Initial studies
demonstrate at least an order of magnitude increase in production is possible; the system
can be scaled up, and that the self-organization of the efficient vascular network is robust.
The work suggests that bioengineered multicellularity may offer efficiency improvements
difficult to achieve with physical engineering approaches.
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Recent developments in genetics, bioengineering, synthetic biology and nanotechnology
have enabled industrial scale biomanufacturing units for the production of many valuable
products [1]. Biopharmaceutical and recombinant enzyme proteins production are of pri-
mary importance within this field [2]. Insulin [3], vanillin [4, 5], antibodies such as peni-
cillin [6], industrially valuable enzymes such as lipase [7], cellulase [8], amylase [9] are already
being produced in large scales with microbial factories. Apart from the enzyme produc-
tions, microbes are also being engineered to produce industrially important nanoparticles
that are used in electronics, drug delivery among others [10,11]; environmentally beneficial
bio-plastics [12], insect silks [13], opiates [14]; bio-fuels such as iso-butanol [15] and various
other chemicals [16] and proteins [17]. These bioreactors are relatively cheap and efficient.
The quality and composition of the medium in which these cell factories are cultivated
highly influence the productivity of the entire system [18]. The optimal medium composi-
tion varies from strain to strain. For example, Escherichia coli is often cultured in shaken
flasks for recombinant protein production [19]. However, in these cases, all the culture com-
ponents are often added at the start, which makes it difficult to control various composition
parameters such as pH value or the level of dissolved nutrients throughout the life cycle
of the cellular factory. As the producer cells grow, they create the product, but they also
produce waste. The accumulation of waste can have adverse effects on the culture, degrade
the product quality, and can make it difficult to isolate the product [18]. Moreover, the
accumulation of the product in the culture can act as a negative feedback loop and inhibit
the production of further product [20], [21], [22].
Efforts to increase the stability and productivity of cellular factory designs frequently
focus on controlling the cell culture during production. The microenvironment of the factory
cells must be kept free of waste and product, and continually replenished with nutrients.
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Closed systems like flasks achieve this by dispersing the waste and product throughout
the container by agitation, while in bioreactors, flow-through processes ensures the cell
microenvironments are regularly replaced with new media. This work explores a possible
alternative solution to the problem of controlling and optimizing the culture.
The evolution of macroscopic organisms demonstrates that large-scale stable cell sys-
tems benefit from a multicellular organization that can provide additional functions such
as nutrient delivery and waste removal, which maintain the system’s efficiency and sta-
bility [23]. Nutrient delivery systems in vertebrates, also known as vascular networks are
formed either through vasculogenesis, a biological process in which scattered vessel cells
organize to form new networks or through angiogenesis, in which new vessels split or sprout
from the existing vessels.
Both vasculogenesis and angiogenesis are known to be primarily driven by chemotaxis,
a biological mechanism in which cells move in response to a chemical gradient, and cell-
cell adhesion [24]. While many questions remain, progress in understanding and exploiting
this process is being made from a bioengineering perspective [25] [26]. In Dahl et al.
[27] tissue-engineered vascular grafts were successfully implanted in baboons and dogs.
Juan M. Melero-Martin et al. [28] showed a robust development of functional vascular
networks is possible in vivo. With additional research in this area, bioengineered cells
could be implemented to form functional vascular networks that could be used as a delivery
mechanism in industrial cell factories.
This paper presents a proof-of-concept cellular factory design in which the producer cell
culture environment is supported by a vascular network, replicating the nutrient delivery and
waste removal process in macroscopic organisms. A simulation study evaluates the potential
of the design for enhanced production from stable cultures. In this design, the vascular net-
works self-organize from randomly distributed bio-engineered cells that have similar physi-
ology to endothelial cells. These newly formed vessels then support the product-producing
cells by delivering nutrients, extracting product, and removing waste.
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The rest of the paper is structured as follows: First, the experimental setup and com-
putational model are described. Second, the proposed cellular factory design is evaluated by
running multiple simulations and measuring saleability, robustness and productivity. Next,
the methods are described that model both vessel de novo formation and vessel network




MODEL EXPERIMENT AND MODEL
An overview of the simulation process that builds and executes a novel design for a
microbial cell factory is given in Figure 2.1. Here a self-organizing vascular network is
formed that provides nutrient delivery and removal of product and waste from the factory
cells that produce the desired product. The process is divided into three distinct phases:
self-organization of the vascular network, determination of the material flow through the
network once it is activated, and finally, the execution of the factory.
At this initial proof-of-concept stage, a two-dimensional model is constructed and eval-
uated. Figure 2.1(a) illustrates the initial state of the simulated factory. Circulatory cells
(blue) that simulate the external circulatory system are arranged as two columns on oppo-
site sides of the production area. The left column represents the source and the right one the
sink, just as in the arterial-venous network architecture in vertebrates [29]. Circulatory cells
are capable of secreting both the long range and the short-range chemoattractant to enable
the vascular cells to connect into the circulatory system. Randomly distributed across the
area in between the two circulatory cell columns are inactive producer cells (yellow) mixed
with bioengineered vascular cells (red), similar to the endothelial cells in vertebrates [24].
In the first phase, the randomly distributed vascular cells self-organize to form a vas-
cular network that is connected to both columns of circulatory cells. This process auto-
matically partitions the producer cells into clusters contained within each network lacunae.
An example of a self-organized system at the end of Phase I is illustrated in Figure 2.1(b).
In the second phase, flow through the vascular system estimated, given the network ar-
chitecture and likely operating conditions shown in Figure 2.1(c), where the magnitude of
the calculated flow is color coded. Finally, the factory is executed. Here, the functioning
vascular network simulation is integrated with the producer cells that consume the nutrient
and secrete the product to simulate the steady state operation of the cell factory. The run-
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ning factory is illustrated in Figure 2.1(d). Note in this case the network provides almost
complete coverage of the producing area, and all cells are active (green) rather than inactive
(yellow).
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(a) Initial State: Random arrangement of vascular cells (red spheres) and inactive
producer cells (yellow spheres). The fixed circulatory cells are shown in blue on both sides.
(b) Phase I: Self-organize the vessel network: Each vascular cell secretes and responds to
a chemoatractant. Strong mutual adhesion builds vessels that connect into a near-regular
network, partitioning the producer cells in each lacunae.
Fig. 2.1: Vascular factory: The three phases in modeling a vascular factory design.
Beginning with morphogenesis, where the vessel network self-organizes, (cont.)
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(c) Phase II: Determine Network Flow: A network of pipes is extracted and a pressure
differential applied (Source and Sink). Individual vessel flow is determined by applying
Poiseuille’s Law. (red is highest, black is lowest)
(d) Phase III: Run the factory: Nutrient flows into the network and is disbursed, activating
the producer cells (green sphere). The network removes the product, which flows to the
sink.
Fig. 2.1: Vascular factory: followed by network analysis where the flow through the
vessels is estimated, then production, where the producer cells run and the nutrient inflow




Thousands of simulations were performed to gain insights into the feasibility and poten-
tial benefits of this vascular factory design. Three specific questions were addressed. First,
how is the productivity of the factory affected by the proportion of vascular cells initially
introduced into the factory? Here, productivity was measured over a series of simulations
in which the ratio of vascular to producer cells was varied. Second, how robust is the self-
organizing process? This was investigated by generating multiple vascular networks under
different random conditions and tabulating a productivity distribution. Finally, how do the
physical dimensions of the factory area influence productivity? Here a range of distances
separating the two circulatory columns was explored and the productivity measured.
To limit computational requirements, the size of the factory is restricted to two dimen-
sions with the height fixed at 1.536mm and the width varied from 1.536mm to 6.144mm.
Results from this study may be extrapolated in the vertical direction since the system has
horizontal symmetry. Each simulation has 780 circulatory cells arranged as two columns
on either side of the grid to simulate the external delivery and product extraction system.
The total number of vascular and producer cells in all the experiments are set to 12,000,
24,000, and 48,000 for the smallest to largest sizes. At the beginning of each execution,
vascular and producer cells are randomly distributed in the area between the circulatory
cell columns (see Figure 2.1(a). In Phase III, the throughput of the system is calculated by
summing the total product removed by the vascular network and circulatory columns over
the period of 2 hours once the factory has reached a steady state.
To address the first question, the simulation was repeated ten times with the ratio of
vascular cells to producer cells varied between 0% to 45% while keeping the total number of
cells constant. For each ratio, the average product throughput was calculated and divided by
the throughput for the case when no vascular system is present to produce a relative measure
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of improvement. The results are displayed in Figure 3.1(b). When the number of vascular
cells is below 20%, the vascular network never completes a path between the two circulatory
columns and no advantage in production is realized. At 20% and 25% the networks are not
robust in that a few don’t connect, and most contain regions of disconnected vessels that
leave areas of the cell culture without support. At 30% and beyond, the vascular network
includes few defects and vessels are well distributed to cover the whole area of producer
cells. Typical examples of networks at different vessel/producer cell ratios are illustrated in
Figure 3.2.
Simulations with functional vascular networks produced a 15 to 40 fold increase in
product produced compared to that produced by simulations without vascular systems (see
Figure 3.1(a) and (b). This is despite the fact that the number of producer cells decreases
in the simulation as the percentage of vascular cells grows. Hence, these experiments show
that vascular networks increase individual cell productivity and thereby the efficiency of
the factory.
For this approach to be viable, the self-organizing step that builds the vascular system
must be insensitive to the initial random arrangement of cells and the inherent stochasticity
of cell movement. In each vascular factory, an effective network that can deliver nutrients
and collect product must be autonomously constructed. In the second set of experiments,
the ratio of vascular and producer cells is fixed at 30%. Multiple simulations were performed,
each with a unique random seed. As shown in Figure 3.1(b), while the vascular networks
formed in each case were distinct, all functioned similarly and produced little variability in
overall production. Hence, the self-organization process is robust.
Finally, the separation distance of circulatory columns was explored. Ideally, circula-
tory columns would be widely spaced, with the self-organized network taking the bulk of
responsibility to support the producer cells. In this study, the height was maintained at
1.536mm, and the width varied between 1.536mm to 6.144mm. Due to limitations in the
simulation architecture, widths were changed by powers of two. Figure 3.1(d) illustrates the
productivity estimates for the three different widths. As can be seen, the productivity per
10
unit area had little variation with the change of grid width and hence prove that produc-
tivity improves linearly with separation distance, supporting a design with fewer physical
pipes. Example of a vascular network for the 1.536mm and 6.144mm width is given in
Figure 3.3(a) and Figure 3.3(b) respectively.
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(a) The influence of % vascularization
(b) Relative product throughput
Fig. 3.1: Evaluation: (a) shows the effect of varying the percentage of vessel cells in the
initial random configuration on the total product throughput per hour; (b) shows the effect
of varying the percentage of vessel cells in the initial random configuration has on relative
productivity. Productivity is measured by dividing throughput of the specific experiment
with the throughput of the factory with no vascular system; (cont.)
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(c) Production distribution for 30% vascularization
(d) Effect of grid size on production per mm2
Fig. 3.1: Evaluation: (c) illustrates the robustness of the self-organizing process as a
histogram of product throughput for networks generated with different random seeds; (d)
shows the effect of increasing the separation between the two circulatory columns. Here the
actual productivity is given in micro grams per hour per µm3 culture
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(a) 15% vessel cells
(b) 25% vessel cells
Fig. 3.2: Proportion of vascular cells: Example networks self-organized from different
proportions of vessel and producer cells. (a) At 15% only isolated and dysfunctional vessels
are formed. (b) At 25%, regions with disconnected vessels are common, leading to areas
of inactive producer cells (yellow). In this case, darker vessel cells signify very low or no
nutrient flow.(Cont.)
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(c) 45% vessel cells
Fig. 3.2: Proportion of vascular cells: (c) At higher densities, many small lacunae form
and all producer cells are active.
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(a) 1.536mm grid example
(b) 6.144mm grid example
Fig. 3.3: Simulation examples with different grid widths: (a) shows an example of
a vascular network with grid size 1.536mm x 1.536mm (b) shows an example of a vascular




An agent-based simulator framework, cDynoMiCs [30] is used in this experiment. cDy-
noMiCs is an extension of iDynoMiCs framework developed by Kreft group at University of
Birmingham [31] specifically for biofilms. cDynoMiCs includes eucaryotic cell modeling with
the addition of extra cellular matrix and cellular mechanisms such as tight junctions and
chemotaxis. Each cell is represented as a spherical particle, which has a particular biomass,
and implements specific mechanisms to reproduce cellular physiology. Biochemically, par-
ticles can secrete or up-take chemicals that are diffused through the domain by execut-
ing reactions. Biomechanically, particles exhibit homogeneous and heterogenous adhesion,
chemotaxis and the formation of tight-junctions. Particles can increase their biomass and
split into two particles, although growth is not included in the vascular cell factory model.
The simulation process interleaves biomechanical stress relaxation where the particles are
moved in response to individual forces, along with the resolution of biochemical processes
such as secretion, up-take and diffusion by a differential equation solver.
4.0.1 Phase I: Self-Organize the Vascular Network
Beginning in the state illustrated in Figure 2.1(a), the vessel and circulatory cells be-
come active and start to secrete chemoattractants, described by the Monod-kinetic reaction
in Equation 4.1. Nc is the concentration of the nutrient initially supplied for chemoattrac-
tant secretion, M is biomass of the vascular or circulatory cell; the diffusion coefficient of
both chemoattractants are set to 1 × 10−13m2s−1 as given in in-vitro angiogenesis experi-
ments by Merks et al [24]. The chemoattractant secreted by the vascular cells has a fast rate
of decay, βv, which creates a steep gradient local to each cell. The chemoattractant secreted
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by the circulatory cells βc has a slower rate of decay creating a longer range gradient.
∂C
∂t
= Dc 52 c+ µc
k
(Nc + k)
Mv − βC (4.1)
The vascular cells respond to the gradient of the chemoattractants by tending to move
“uphill”, a process described in [32]. Let p be a particle that responds to chemoattractant
C. A random unit vector ~c is generated and considered as a potential chemotactic force on
p. The local gradient of chemoattractant across p in direction ~c is determined by sampling
C ahead of p, referred to as C+, and behind p, referred to as C−. The magnitude of force
F in direction ~c is given by the equation 4.2 [24], where λ is the parameter that controls









The force ∆F ·~c is only applied to the particle if ∆F > 0. Once all particles have been
assigned forces, the system is relaxed by a shoving algorithm that moves the particles to
avoid overlapping. In this way, the vessel particles push through the production particles,
form clumps due to attractive adhesive forces, and then buckle and extend immature vessels.
The system eventually reaches the morphology illustrated in Figure 4.1(c), in which all
biomechanical forces are relaxed and biochemical concentrations stable. Figure 4.1 shows
the chemoattractant distribution during formation and at the stable state, along with the
corresponding final cellular morphology.
4.0.2 Phase II: Determine Network Flow
The process to determine material flow through the network is illustrated in Figure 4.2
and consists of first extracting a network-of-pipes representation of the cellular morphology,
then simulating its execution. To identify the pipes and their connectivity, the output file
produced by the simulation is visualized as an image using pov-ray software [33]. Particles
are rendered as illuminated spheres of differing colors signifying their type illustrated in
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Figure 4.2(a). This image is then converted to a binary image Figure 4.2(b) and the local
width of each vessel is extracted using the Fiji software [34], an extension of ImageJ [35] [36].
The local width measure is needed during the last step of the process. The binary image
is skeletonized using the algorithm by Lee et al. [37] (illustrated in Figure 4.2(c)) and
implemented by the Ignacio Arganda-Carreras [38]. The skeletonized image is transformed
to a skeletonized graph (see Figure 4.2(d)) using AnalyzeSkeleton algorithm by also by
Carreras et al. [38]. This skeletonized graph is converted to a planar graph with each edge
representing a unique vessel in the network. Each edge is assigned a radius (half the average
local width) and a length. The network is now represented as a graph of pipes with n nodes
and m vessels and is ready for the final step.
First, a graph traversal is performed to determine if there exists a path through the
network connecting the source (the upper left) and sink (lower right) in Figure 2.1(b). Each
node i in the graph is assigned an unknown variable Pi representing the pressure at node
i. Each edge (i, j) in the graph is assigned an unknown variable Q(i,j) representing the
flow through i, j, and an unknown variable ∆P(i,j) representing the pressure drop Pi − Pj .
Next a series of equations of the graph are generated using Poiseuille’s Law [39] as given
in Equations 4.3, 4.4 and 4.5 relating Q(i,j) and Pi to characteristics of the network (r and
l the radius and length of each vessel) and operating conditions (P1 and Pn, the source
and sink pressure respectively). For this simulation ∆P(1,n) was set at 1 KPa [40]. The
viscosity of the fluid η is set to that of water at 25oc. The following linear equations are
generated:





For each node, i with σ(i) neighbors:
∑
k∈σ(i)
Q(i,k) = 0 (4.4)
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For each lacunae cycle φ(k):
∑
(i,j)∈φ(k)
∆P(i,j) = 0 (4.5)
Finally, these equations are solved using a linear equation solver to calculate the flow
rate Q(i,j) through all the vessels and pressure drop ∆P(i,j) over each vessel. The final
solution is illustrated in Figure 4.2(e) with a color map signifying the magnitude of the
flow.
4.0.3 Phase III: Run the Factory
To execute the factory, each vessel provides nutrient N and removes product P along
the vessel extent. The rate of N and P increases with flow rate and vessel radius but is
limited by transfer rates through the vessel walls [41]. Models have been developed for
engineered vascular networks in [42] and in vitro networks in [43]. This work employs a
simplified model described below.









where Q(i,j) is the flow rate determined from Phase II, ρn is a transfer constant, and r is
the radius of the vessel. The rate of nutrient delivery is controlled by the flow in the vessel,
represented as a hill function of Q(i,j), and the amount of N in the microenvironment. As
the nutrient in microenvironment decreases, the rate of nutrient delivery increases, defined
in the function above.
The availability of nutrient will activate the producer cells that will begin to consume








Mp +Dp 52 P (4.7)
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where Mp is producer cell biomass. P is produced from N following Michaelis-Menten
kinetics, where the saturation of enzymes involved in P production is considered (kp) [44].
The negative feedback due to product inhibition is also taken into account, with a corre-
spondent inhibitor constant (ki) [20], [21] and [22].







(kp + P )
(4.8)
where Q(i,j) is the flow rate determined from Phase II, ρp is a transfer constant and r
is the vessel radius. The rate is controlled by the flow similarly to N , but in this case, the
effect of P in the microenvironment is different. Here as the amount of P increases, the
rate of removal increases.
Nutrient will be consumed by the producer cells in direct correspondence to the pro-







(ki + P )
Mp +Dp 52 N (4.9)
A solution to these equations is illustrated in Figure 4.3(b) and (c) for vascular network
with 30% vascular cells. Note low product concentrations in areas close to vessels with higher
flow rates, representing high-efficiency regions of the factory.
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(a) During formation
(b) Steady state distribution
Fig. 4.1: Phase I: Self-organizing the network: The distribution of chemoattractant during
vessel formation and at a steady state, (Cont.)
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(c) Steady state morphology
Fig. 4.1: Phase I: along with the final vessel network formed.
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a) Vessel morphology b) Binary image c) Skeletonize lines
d) Extract graph e) Solve for flow
Fig. 4.2: Phase II: First a network of pipes is extracted from the vessel morphology in
steps (a) through (d). Second, the flow rate of material through each vessel is determined,
and illustrated in (e) using a color map to signify flow rate magnitude. Red is highest flow
rate and black is the lowest.
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(a) Early N distribution
(b) Stable state N distribution
Fig. 4.3: Phase III: Running the factory: The distribution of nutrient (a) when the vessel
flow begins, but the producer cells are not yet active, (b) at steady state nutrient distribution
when the factory is running; note that all extra-vessel nutrient is consumed. (Cont.)
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(c) Stable state P distrubution
Fig. 4.3: Phase III: (c) the product distribution (with blue being low concentration and




This work presents a possible vascular factory design and a computational demon-
stration of its feasibility. The potential increases in cell factory productivity were assessed
through an integrated model of vessel morphogenesis and dynamic vascular system function-
ing. The robustness of vessel self-organization was evaluated over a population of random
initial states.
To realize such a design, specific cell types must be engineered that exhibit the needed
mechanisms, such as chemotaxis, and be able to function together in stable tissue. Recent
work in the engineering of induced pluripotent stem cells may hold the key to advances in
this area [45], [46] and for vascular systems in particular [47]. Additionally, a means must
be devised for linking the biological vessels with the physical circulatory system. Here,
advances in microfabrication may be of relevance [48].
To support this bioengineering effort, high fidelity models of specific cell types are
needed so that simulated cells and real cells may be brought into correspondence. For
insights provided by simulations to be useful, simulated cells must accurately reproduce
known cell physiology and realistically implement the underlying biomechanical and bio-
chemical processes at work. Recently, multiscale models of cancer have advanced cell model
validation techniques, which are applicable here. In [49] specific parameters controlling
cell physiology were tuned to replicate patient-specific observations, leading to more potent
treatment recommendations. Similar parameter tuning approaches have been successfully
applied in a bioengineered application to accurately determine VEGF autoregulation [30].
Another work is building a repository of simulated cell types and their mappings to real
cell lines [50].
With the capability to simulate the functioning of the vascular factory, alternative
designs may be evaluated and compared. Traditionally, such searches have optimized for
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physical characteristics of the design such as flow, materials, pipe configurations, tempera-
ture, substrate concentrations and so on [51], [52]. In systems that exploit multicellularity,
additional searches can be conducted to help identify particular cell physiology that lead
to the most efficient vascular architecture. In individual-particle based models, such as em-
ployed here, each cell type exhibits certain mechanisms controlled by parameters, such as
λ, which modulates the force response to the chemoattractant gradient. By evaluating the
influence that changing λ has on the productivity and stability of the vascular factory, an
optimal λ could be determined. Given the coupled nature of the model, it makes sense to
explore the combinatorial space of possible parameter values. In [53] such an optimization
search was performed to identify possible interventions in angiogenesis to reduce tumor
growth in breast cancer. In this case, due to the vast number of parameters that affect
angiogenesis, a massively parallel genetic algorithm was employed [54], with the objective
being to minimize or reverse tumor growth. Once optimal parameter values have been de-
termined, the challenging synthetic biology problem of manipulating the cells to implement
the prescribed behavior remains. In general, an evaluation of a single parameter vector
will require many simulations due to the stochastically inherent in the process. Such ex-
tensive searches through model space can require millions of simulations and necessitates a
significant speedup of simulator execution time.
In addition to rapid execution, the scale of the simulations needs to be expanded to
billions of cells in three-dimensional space. We would anticipate the efficiency improvements
would be even more significant in three dimensions because the vessels can support far
more producer cells. Two simulation frameworks have recently been developed that have
the potential to satisfy these requirements: A simulation system for cancer development
described in [55], and Biocellion [56]. Both these systems implement an individual-based
approach similar to cDynoMiCs employed here. Biocellion is implemented as a distributed
architecture executable on the cloud [57] and is capable of simulating complex models in a
matter of a few hours. Biocellion has the potential to simulate an industrial-scale vascular
microbial cell factory consisting of trillions of cells.
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In summary, this simulation study has demonstrated that vascular cell factories have
the potential to be robust, scalable and lead to significant increases in productivity. How-
ever, to realize such designs many computational and bioengineering challenges remain.
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Protocol File for the model
A.1 Description
This xml document function as the definition of the model and as the input to the
simulation framework.
A.2 Protocol File
1 <?xml version=” 1 .0 ” encoding=”utf−8” standalone=”no”?>
2 < !−−
3 #########################################################################









13 <s imu la tor>
14 <param name=” restartPrev iousRun ”> f a l s e</param>
15 <param name=”randomSeed”>5515</param>
16 <param name=”outputPeriod ” un i t=”hour”>1</param>
17
18 <t imeStep>
19 <param name=” adapt ive ”> f a l s e</param>
20 <param name=” t imeStepIn i ” un i t=”hour”>. 05</param>
21 <param name=”timeStepMin” un i t=”hour”>0 .025</param>
22 <param name=”timeStepMax” un i t=”hour”>1</param>
36
23 <param name=”endOfSimulation ” un i t=”hour”>22</param>
24 </ timeStep>
25 < !−− The AGENTTIMESTEP which should always be EQUAL or LOWER than the
g l oba l time step −−>
26 <param name=”agentTimeStep” un i t=”hour”>0 .05</param>







34 <param name=”useAgentFi le ”> f a l s e</param>
35 <param name=” inputAgentFileURL”>agent Sta te ( l a s t ) . xml</param>
36 <param name=” useBulkFi l e ”> f a l s e</param>








45 <s o l u t e domain=”MyYeastColony” name=”Chemotact icNutr ient ”>
46 <param name=” d i f f u s i v i t y ” un i t=”m2. day−1”>8 .64 e−9</param>
47 <param name=” a i r D i f f u s i v i t y ” un i t=”m2. day−1”>8 .64 e−9</param>
48 <param name=”writeOutput ”>t rue</param>
49 </ s o l u t e>
50
51 <s o l u t e domain=”MyYeastColony” name=”Attract ”>
52 <param name=” d i f f u s i v i t y ” un i t=”m2. day−1”>8 .64 e−9</param>
53 <param name=” a i r D i f f u s i v i t y ” un i t=”m2. day−1”>8 .64 e−9</param>
54 <param name=”decayRate”>0 .04</param>
55 <param name=”writeOutput ”>t rue</param>
56 </ s o l u t e>
37
57
58 <s o l u t e domain=”MyYeastColony” name=”Gradient ”>
59 <param name=” d i f f u s i v i t y ” un i t=”m2. day−1”>8 .64 e−9</param>
60 <param name=” a i r D i f f u s i v i t y ” un i t=”m2. day−1”>8 .64 e−9</param>
61 <param name=”decayRate”>0.000001</param>
62 <param name=”writeOutput ”>t rue</param>
63 </ s o l u t e>
64
65 <s o l u t e domain=”MyYeastColony” name=”Nutr ient ”>
66 <param name=” d i f f u s i v i t y ” un i t=”m2. day−1”>8 .64 e−11</param>
67 < !−−
68 t h i s and next two s o l u t e s are more complex than previous , so should have
lower d i f f u s i v i t y
69 −−>
70 <param name=” a i r D i f f u s i v i t y ” un i t=”m2. day−1”>8 .64 e−11</param>
71 <param name=”writeOutput ”>t rue</param>
72 </ s o l u t e>
73
74 <s o l u t e domain=”MyYeastColony” name=”Product”>
75 <param name=” d i f f u s i v i t y ” un i t=”m2. day−1”>8 .64 e−11</param>
76 <param name=” a i r D i f f u s i v i t y ” un i t=”m2. day−1”>8 .64 e−11</param>
77 <param name=”writeOutput ”>t rue</param>
78 </ s o l u t e>
79
80 <s o l u t e domain=”MyYeastColony” name=”Evaluator ”>
81 <param name=” d i f f u s i v i t y ” un i t=”m2. day−1”>8 .64 e−11</param>
82 <param name=” a i r D i f f u s i v i t y ” un i t=”m2. day−1”>8 .64 e−11</param>
83 <param name=”writeOutput ”>t rue</param>
84 </ s o l u t e>
85
86 <p a r t i c l e name=”biomass ”>
87 <param name=” dens i ty ” un i t=”g .L−1”>150</param>
88 </ p a r t i c l e>
89 <p a r t i c l e name=” i n e r t ”>
90 <param name=” dens i ty ” un i t=”g .L−1”>150</param>
38
91 </ p a r t i c l e>
92 <p a r t i c l e name=” capsu l e ”>
93 <param name=” dens i ty ” un i t=”g .L−1”>75</param>








102 <param name=” isConstant ”>t rue</param>
103 <param name=”D” uni t=”h−1”>0 .6</param>
104 <s o l u t e name=”Attract ”>
105 <param name=”Sbulk” un i t=”g .L−1”>0 .0</param>
106 <param name=”Sin ” un i t=”g .L−1”>0</param>
107 <param name=” isConstant ”>t rue</param>
108 </ s o l u t e>
109 <s o l u t e name=”Gradient ”>
110 <param name=”Sbulk” un i t=”g .L−1”>0 .0</param>
111 <param name=”Sin ” un i t=”g .L−1”>0</param>
112 <param name=” isConstant ”>t rue</param>
113 </ s o l u t e>
114 <s o l u t e name=”Nutr ient ”>
115 <param name=”Sbulk” un i t=”g .L−1”>0 .0</param>
116 <param name=”Sin ” un i t=”g .L−1”>0</param>
117 <param name=” isConstant ”>t rue</param>
118 </ s o l u t e>
119 <s o l u t e name=”Product”>
120 <param name=”Sbulk” un i t=”g .L−1”>0 .0</param>
121 <param name=”Sin ” un i t=”g .L−1”>0</param>
122 <param name=” isConstant ”>t rue</param>
123 </ s o l u t e>
124 <s o l u t e name=”Evaluator ”>
125 <param name=”Sbulk” un i t=”g .L−1”>0 .0</param>
39
126 <param name=”Sin ” un i t=”g .L−1”>0</param>
127 <param name=” isConstant ”>t rue</param>




132 < !−−This bulk i s attached to the bottom of the g r id and prov ide the
nu t r i e n t s nece s sa ry f o r the chemoattractant s e c r e t i o n−−>
133 <s o l u t e name=”Chemotact icNutr ient ”>
134 <param name=”Sbulk” un i t=”g .L−1”>30</param>
135 <param name=”Sin ” un i t=”g .L−1”>30</param>
136 <param name=” isConstant ”>t rue</param>
137 </ s o l u t e>
138 </bulk>
139 <computationDomain name=”MyYeastColony”>
140 <g r id nDim=”2” nI=”129” nJ=”257” nK=”1”/>
141 <param name=” r e s o l u t i o n ” un i t=”um”>4</param>
142 <param name=”boundaryLayer” un i t=”um”>1</param>
143 <param name=” b i o f i lmD i f f u s i v i t y ”>0 .8</param>
144 <param name=” sp e c i f i cA r e a ” un i t=”m2.m−3”>80</param>
145
146 < !−− This makes the two s i d e s o f the g r id ( In the rendered p i c ture ,
top and bottom cont inous and making i t i n f i n i t e c y c l i c )−−>
147 <boundaryCondition c l a s s=”BoundaryCyclic ” name=”y0z”>
148 <shape c l a s s=”Planar ”>
149 <param name=” po int In ” x=”−1” y=”0” z=”0” />
150 <param name=”vectorOut ” x=”−1” y=”0” z=”0” />
151 </ shape>
152 <shape c l a s s=”Planar ”>
153 <param name=” po int In ” x=”129” y=”0” z=”0” />




158 <boundaryCondition c l a s s=”BoundaryGasMembrane” name=”x0z”>
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159 <param name=”canAttachTo”>t rue</param>
160 <param name=”bulk”>MyTank</param>
161 <param d e t a i l=”Attract ” name=” isPermeableTo” un i t=”m2. day−1”>8 .64 e−9
</param>
162 <param d e t a i l=”Gradient ” name=” isPermeableTo” un i t=”m2. day−1”>8 .64 e
−9</param>
163 <param d e t a i l=”Nutr ient ” name=” isPermeableTo” un i t=”m2. day−1”>8 .64 e
−11</param>
164 <param d e t a i l=”Product” name=” isPermeableTo” un i t=”m2. day−1”>8 .64 e
−11</param>
165 <shape c l a s s=”Planar ”>
166 <param name=” po int In ” x=”0” y=”−1” z=”0”/>




171 <boundaryCondition c l a s s=”BoundaryGasMembrane” name=”xNz”>
172 <param name=”canAttachTo”>t rue</param>
173 <param name=”bulk”>MyTank</param>
174 <param d e t a i l=”Attract ” name=” isPermeableTo” un i t=”m2. day−1”>8 .64 e−9
</param>
175 <param d e t a i l=”Gradient ” name=” isPermeableTo” un i t=”m2. day−1”>8 .64 e
−9</param>
176 <param d e t a i l=”Nutr ient ” name=” isPermeableTo” un i t=”m2. day−1”>8 .64 e
−11</param>
177 <param d e t a i l=”Product” name=” isPermeableTo” un i t=”m2. day−1”>8 .64 e
−11</param>
178 <shape c l a s s=”Planar ”>
179 <param name=” po int In ” x=”0” y=”257” z=”0”/>




184 <boundaryCondition c l a s s=”BoundaryGasMembrane” name=”x0y”>
185 <param name=”bulk”>MySecondTank</param>
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186 <param d e t a i l=”Chemotact icNutr ient ” name=” isPermeableTo” un i t=”m2.
day−1”>8 .64 e−9</param>
187 <shape c l a s s=”Planar ”>
188 <param name=” po int In ” x=”0” y=”0” z=”−1”/>




193 <boundaryCondition c l a s s=”BoundaryZeroFlux” name=”x0y”>
194 <shape c l a s s=”Planar ”>
195 <param name=” po int In ” x=”0” y=”0” z=”1”/>











207 < !−−Replaced the monod k i n e t i c f a c t o r to chemotact ic nu t r i en t which
prov ide s the nu t r i t i o n f o r the chemotact ic c e l l s i n i t i a l l y−−>
208 <r e a c t i on catalyzedBy=”biomass ” c l a s s=”React ionFactor ” name=”
At t ra c tSe c r e t i on ”>
209 <param name=”muMax” un i t=”hour−1”>3 .6</param>
210 <k i n e t i cFac t o r c l a s s=”MonodKinetic” s o l u t e=”Chemotact icNutr ient ”>< !−−
Monod k i n e t i c because the re are p ro t e in t r an spo r t e r s that have
a f f i n i t y towards the a t t r a c t an t s they t ranspor t f o r s e c r e t i o n−−>
211 <param name=”Ks” un i t=”g .L−1”>0 .12 e−3</param>
212 </ k i n e t i cFac t o r>
213 <y i e l d>
214 <param name=”Chemotact icNutr ient ” un i t=”g . g−1”>−0.1</param>
215 <param name=”Attract ” un i t=”g . g−1”>0 .1</param>
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216 </ y i e l d>
217 </ r e a c t i on>
218
219 <r e a c t i on catalyzedBy=”biomass ” c l a s s=”React ionFactor ” name=”
Grad ientSec re t i on ”> < !−−l e av ing F i r s t Order Kine t i c s i n c e long range
a t t r a c t an t comes from the s ink−−>
220 <param name=”muMax” un i t=”hour−1”>3 .6</param>
221 <k i n e t i cFac t o r c l a s s=” F i r s tOrde rKine t i c ”/>
222 <y i e l d>
223 <param name=”Chemotact icNutr ient ” un i t=”g . g−1”>−0.1</param>
224 <param name=”Gradient ” un i t=”g . g−1”>0 .1</param>
225 </ y i e l d>
226 </ r e a c t i on>
227
228 <r e a c t i on catalyzedBy=”biomass ” c l a s s=”React ionFactor ” name=”
ProductSecret ion ”>
229 <param name=”muMax” un i t=”hour−1”>0 .5</param> < !−−example o f
product ion ra t e o f van i l i n , r e f e r e n c e Bernard , 1999 −−>
230 <k i n e t i cFac t o r c l a s s=”MonodKinetic” s o l u t e=”Nutr ient ”>
231 <param name=”Ks” un i t=”g .L−1”>1 .2 e−3</param>
232 </ k i n e t i cFac t o r>
233 <k i n e t i cFac t o r c l a s s=” S imp l e Inh ib i t i on ” s o l u t e=”Product”>
234 <param name=”Ki” un i t=”g .L−1”>0 .18</param>
235 </ k i n e t i cFac t o r>
236 <y i e l d>
237 <param name=”Nutr ient ” un i t=”g . g−1”>−0.1</param>
238 <param name=”Product” un i t=”g . g−1”>0 .1</param>
239 </ y i e l d>
240 </ r e a c t i on>
241
242 < !−−muMax o f t h i s f i r s t order k i n e t i c i s c on t r o l l e d by equat ion s im i l a r
to the monod k i n e t i c equat ion
243 which depends on the f low ra t e o f the nu t r i e n t s through the vas cu l a r
network branch where that p a r t i c u l a r c e l l r e s i d e s .
244 muMax and Ks o f that equat ion i s a l s o same .−−>
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245 <r e a c t i on catalyzedBy=”biomass ” c l a s s=”React ionFactor ” name=”
Nut r i en tSec r e t i on ”> < !−−nut r i en t s e c r e t i o n and product uptake back
in to the g r id o f red c e l l s can be the same−−>
246 <param name=”muMax” un i t=”hour−1”>0 .0</param> < !−−va lue s in range f o r
nu t r i e n t s uptake/ s e c r e t i o n f o r p lant c e l l s , Ch r i sp e e l s at a l . −−>
247 <k i n e t i cFac t o r c l a s s=” F i r s tOrde rKine t i c ”/>
248 <k in e t i cFac t o r c l a s s=” S imp l e Inh ib i t i on ” s o l u t e=”Nutr ient ”>
249 <param name=”Ki” un i t=”g .L−1”>0 .09</param>
250 </ k i n e t i cFac t o r>
251 <y i e l d>
252 <param name=”Nutr ient ” un i t=”g . g−1”>0 .1</param>
253 </ y i e l d>
254 </ r e a c t i on>
255
256 < !−−muMax o f t h i s monod k i n e t i c i s c o n t r o l l e d by equat ion s im i l a r to the
monod k i n e t i c equat ion
257 which depends on the f low ra t e through the vas cu l a r network branch where
that p a r t i c u l a r c e l l r e s i d e s .
258 muMax o f that equat ion i s a l s o 1 .1−−>
259 <r e a c t i on catalyzedBy=”biomass ” c l a s s=”React ionFactor ” name=”
ProductUptake”>
260 <param name=”muMax” un i t=”hour−1”>0 .0</param>
261 <k i n e t i cFac t o r c l a s s=”MonodKinetic” s o l u t e=”Product”>
262 <param name=”Ks” un i t=”g .L−1”>0 .15 e−3</param> < !−−lower
a f f i n i t y to product , to speed up uptake−−>
263 </ k i n e t i cFac t o r>
264 <y i e l d>
265 <param name=”Product” un i t=”g . g−1”>−0.1</param>
266 <param name=”Evaluator ” un i t=”g . g−1”>0 .1</param>
267 </ y i e l d>








275 <s o l v e r c l a s s=” SolverS imple ” domain=”MyYeastColony” name=” s o l u t e s ”>
276 <param name=” ac t i v e ”>t rue</param>
277 <param name=”preStep ”>150</param>
278 <param name=”postStep ”>150</param>
279 <param name=” coarseStep ”>1500</param>
280 <param name=”nCycles ”>5</param>
281 <r e a c t i on name=”At t ra c tSe c r e t i on ”/>
282 <r e a c t i on name=”Grad ientSec re t i on ”/>
283 <r e a c t i on name=”Nut r i en tSec r e t i on ”/>
284 <r e a c t i on name=”ProductSecret ion ”/>
285 <r e a c t i on name=”ProductUptake”/>









295 <param name=” r e s o l u t i o n ” un i t=”um”>4</param>
296 <param name=”shovingMaxNodes”>2e6</param>
297 <param name=” shov ingFract ion ”>0 .0025</param>
298 <param name=” shovingMaxIter ”>1000</param>








307 <s p e c i e s c l a s s=”Yeast” name=”MovingCells ”>
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308 <p a r t i c l e name=”biomass ”>
309 <param name=”mass” un i t=” fg ”>10000</param>
310 </ p a r t i c l e>
311 <p a r t i c l e name=” i n e r t ”>
312 <param name=”mass” un i t=” fg ”>0</param>
313 </ p a r t i c l e>
314 <param name=” co l o r ”>red</param>
315 <param name=”computationDomain”>MyYeastColony</param>
316 <param name=”divRadius ” un i t=”um”>3000</param>
317 <param name=”deathRadius ” un i t=”um”>0</param>
318 <param name=” shoveFactor ” un i t=”um”>1</param>
319 <param name=” shoveLimit ” un i t=”um”>0 .0</param>
320 <param name=”epsMax”>0 .5</param>
321 <param name=”kHyd” un i t=”hr−1”>0 .1</param>
322 <param name=” attachCreateFactor ”>1 .0</param>
323 <param name=” attachDestroyFactor ”>2</param>
324 <r e a c t i on name=”At t ra c tSe c r e t i on ” s t a tu s=” a c t i v e ”/>
325 <r e a c t i on name=”Nut r i en tSec r e t i on ” s t a tu s=” ac t i v e ”/>
326 <r e a c t i on name=”ProductUptake” s t a tu s=” ac t i v e ”/>
327 <chemotaxis>
328 <chemotact ic s t r ength=” 2 .25 ” withSo lute=”Attract ” c on t a c t I nh i b i t i o n=
”1”/>
329 <chemotact ic s t r ength=”2” withSo lute=”Gradient ” c on t a c t I nh i b i t i o n=”0
”/>
330 </ chemotaxis>
331 <t i gh tJunc t i on s>
332 <t i gh tJunc t i on s t i f f n e s s=” 0 .05 ” wi thSpec i e s=”MovingCells ”/>
333 </ t i gh tJunc t i on s>
334 <i n i tArea number=”7200”>
335 <param name=”birthday ” un i t=”hour”>0</param>
336 <coo rd ina t e s x=”1” y=”13” z=”0”/>
337 <coo rd ina t e s x=”512” y=”1016” z=”0”/>
338 </ in i tArea>
339 </ s p e c i e s>
340 <s p e c i e s c l a s s=”Yeast” name=”Consumer”>
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341 <p a r t i c l e name=”biomass ”>
342 <param name=”mass” un i t=” fg ”>10000</param>
343 </ p a r t i c l e>
344 <p a r t i c l e name=” i n e r t ”>
345 <param name=”mass” un i t=” fg ”>0</param>
346 </ p a r t i c l e>
347 <param name=” co l o r ”>green</param>
348 <param name=”computationDomain”>MyYeastColony</param>
349 <param name=”divRadius ” un i t=”um”>3000</param>
350 <param name=”deathRadius ” un i t=”um”>0</param>
351 <param name=” shoveFactor ” un i t=”um”>1</param>
352 <param name=” shoveLimit ” un i t=”um”>0 .0</param>
353 <param name=”epsMax”>0 .5</param>
354 <param name=”kHyd” un i t=”hr−1”>0 .1</param>
355 <r e a c t i on name=”ProductSecret ion ” s t a tu s=” ac t i v e ”/>
356 <entryCondi t ions>
357 <entryCondit ion type=” s o l u t e ” name=”Nutr ient ”>
358 <param name=” fromSpec ie s ”>ConsumerInactive</param>
359 <param name=” switch ”>greaterThan</param>
360 <param name=” concent ra t i on ” un i t=”g .L−1”>0 .099</param>
361 </ entryCondit ion>
362 </ entryCondi t ions>
363 <switch ingLags>
364 <switchingLag toSpec i e s=”ConsumerInactive ” value=”2” un i t=”hour”/>
365 </ switch ingLags>
366 </ s p e c i e s>
367 <s p e c i e s c l a s s=”Yeast” name=”ConsumerInactive ”>
368 <p a r t i c l e name=”biomass ”>
369 <param name=”mass” un i t=” fg ”>10000</param>
370 </ p a r t i c l e>
371 <p a r t i c l e name=” i n e r t ”>
372 <param name=”mass” un i t=” fg ”>0</param>
373 </ p a r t i c l e>
374 <param name=” co l o r ”>ye l low</param>
375 <param name=”computationDomain”>MyYeastColony</param>
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376 <param name=”divRadius ” un i t=”um”>3000</param>
377 <param name=”deathRadius ” un i t=”um”>0</param>
378 <param name=” shoveFactor ” un i t=”um”>1</param>
379 <param name=” shoveLimit ” un i t=”um”>0 .0</param>
380 <param name=”epsMax”>0 .5</param>
381 <param name=”kHyd” un i t=”hr−1”>0 .1</param>
382 <entryCondi t ions>
383 <entryCondit ion type=” s o l u t e ” name=”Nutr ient ”>
384 <param name=” fromSpec ie s ”>Consumer</param>
385 <param name=” switch ”>lessThan</param>
386 <param name=” concent ra t i on ” un i t=”g .L−1”>0 .1</param>
387 </ entryCondit ion>
388 </ entryCondi t ions>
389 <i n i tArea number=”16800”>
390 <param name=”birthday ” un i t=”hour”>0</param>
391 <coo rd ina t e s x=”1” y=”13” z=”0”/>
392 <coo rd ina t e s x=”512” y=”1016” z=”0”/>
393 </ in i tArea>
394 </ s p e c i e s>
395 <s p e c i e s c l a s s=”Yeast” name=” P ipeCe l l sLe f t ”>
396 <p a r t i c l e name=”biomass ”>
397 <param name=”mass” un i t=” fg ”>10000</param>
398 </ p a r t i c l e>
399 <p a r t i c l e name=” i n e r t ”>
400 <param name=”mass” un i t=” fg ”>0</param>
401 </ p a r t i c l e>
402 <param name=” co l o r ”>blue</param>
403 <param name=” f i x ed ”>t rue</param>
404 <param name=”computationDomain”>MyYeastColony</param>
405 <param name=”divRadius ” un i t=”um”>3000</param>
406 <param name=”deathRadius ” un i t=”um”>0</param>
407 <param name=” shoveFactor ” un i t=”um”>1</param>
408 <param name=” shoveLimit ” un i t=”um”>0 .0</param>
409 <param name=”epsMax”>0 .5</param>
410 <param name=”kHyd” un i t=”hr−1”>0 .1</param>
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411 <param name=” attachCreateFactor ”>1 .0</param>
412 <param name=” attachDestroyFactor ”>2</param>
413 <param name=” tightJunctionToBoundaryStrength ”>0 .5</param>
414 <param name=”attachToBoundaryCreateFactor ”>1 .1</param>
415 <param name=”attachToBoundaryDestroyFactor ”>1 .8</param>
416 <r e a c t i on name=”At t ra c tSe c r e t i on ” s t a tu s=” a c t i v e ”/>
417 <r e a c t i on name=”Grad ientSec re t i on ” s t a tu s=” ac t i v e ”/>
418 <r e a c t i on name=”Nut r i en tSec r e t i on ” s t a tu s=” ac t i v e ”/>
419 <r e a c t i on name=”ProductUptake” s t a tu s=” ac t i v e ”/>
420 <t i gh tJunc t i on s>
421 <t i gh tJunc t i on s t i f f n e s s=” 0 .08 ” wi thSpec i e s=” P ipeCe l l sLe f t ”/>
422 </ t i gh tJunc t i on s>
423 <i n i tArea number=”390” shape=” f i l l e dB l o c k ”>
424 <param name=”birthday ” un i t=”hour”>0</param>
425 <coo rd ina t e s x=”1” y=”1017” z=”0”/>
426 <coo rd ina t e s x=”512” y=”1028” z=”0”/>
427 <b locks bars=”1” c o l s=”3” rows=”128”/>
428 </ in i tArea>
429 </ s p e c i e s>
430 <s p e c i e s c l a s s=”Yeast” name=”PipeCe l l sR ight ”>
431 <p a r t i c l e name=”biomass ”>
432 <param name=”mass” un i t=” fg ”>10000</param>
433 </ p a r t i c l e>
434 <p a r t i c l e name=” i n e r t ”>
435 <param name=”mass” un i t=” fg ”>0</param>
436 </ p a r t i c l e>
437 <param name=” co l o r ”>blue</param>
438 <param name=” f i x ed ”>t rue</param>
439 <param name=”computationDomain”>MyYeastColony</param>
440 <param name=”divRadius ” un i t=”um”>3000</param>
441 <param name=”deathRadius ” un i t=”um”>0</param>
442 <param name=” shoveFactor ” un i t=”um”>1</param>
443 <param name=” shoveLimit ” un i t=”um”>0 .0</param>
444 <param name=”epsMax”>0 .5</param>
445 <param name=”kHyd” un i t=”hr−1”>0 .1</param>
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446 <param name=” attachCreateFactor ”>1 .0</param>
447 <param name=” attachDestroyFactor ”>2</param>
448 <param name=” tightJunctionToBoundaryStrength ”>0 .5</param>
449 <param name=”attachToBoundaryCreateFactor ”>1 .1</param>
450 <param name=”attachToBoundaryDestroyFactor ”>1 .8</param>
451 <r e a c t i on name=”Att ra c tSe c r e t i on ” s t a tu s=” a c t i v e ”/>
452 <r e a c t i on name=”Grad ientSec re t i on ” s t a tu s=” ac t i v e ”/>
453 <r e a c t i on name=”Nut r i en tSec r e t i on ” s t a tu s=” ac t i v e ”/>
454 <r e a c t i on name=”ProductUptake” s t a tu s=” ac t i v e ”/>
455 <t i gh tJunc t i on s>
456 <t i gh tJunc t i on s t i f f n e s s=” 0 .08 ” wi thSpec i e s=”PipeCe l l sR ight ”/>
457 </ t i gh tJunc t i on s>
458 <i n i tArea number=”390” shape=” f i l l e dB l o c k ”>
459 <param name=”birthday ” un i t=”hour”>0</param>
460 <coo rd ina t e s x=”1” y=”1” z=”0”/>
461 <coo rd ina t e s x=”512” y=”12” z=”0”/>
462 <b locks bars=”1” c o l s=”3” rows=”128”/>
463 </ in i tArea>
464 </ s p e c i e s>
465 </ idynomics>
